As of April 16, 2025, Arbutus Biopharma (ABUS) has a market cap of $0.61 billion USD. According to our data, Arbutus Biopharma is ranked No.5730 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.61 B |
-2.35%
|
Dec 31, 2024 | $0.62 B |
30.80%
|
Dec 29, 2023 | $0.47 B |
7.30%
|
Dec 30, 2022 | $0.44 B |
-40.10%
|
Dec 31, 2021 | $0.74 B |
9.58%
|
Dec 31, 2020 | $0.67 B |
27.70%
|
Dec 31, 2019 | $0.53 B |
-27.42%
|
Dec 31, 2018 | $0.73 B |
-24.16%
|
Dec 29, 2017 | $0.96 B |
106.12%
|
Dec 30, 2016 | $0.46 B |
-44.94%
|
Dec 31, 2015 | $0.84 B |
-70.63%
|
Dec 31, 2014 | $2.87 B |
90.09%
|
Dec 31, 2013 | $1.51 B |
60.69%
|
Dec 31, 2012 | $0.94 B |
230.67%
|
Dec 30, 2011 | $0.28 B |
-68.09%
|
Dec 31, 2010 | $0.89 B |
2.17%
|
Dec 31, 2009 | $0.87 B |
217.24%
|
Dec 31, 2008 | $0.27 B |
-68.13%
|
Dec 31, 2007 | $0.86 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.77 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Vir Biotechnology
VIR
|
$0.77 B |
-0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
Market Cap | = | ABUS Stock Price | * | ABUS Shares Outstanding |
= | $3.16 | * | 0.19 B | |
= | $0.61 B |